Recent research into Semaglutide are yielding promising results regarding fat reduction. Initially developed for treating type 2 diabetes , this GLP-1 receptor agonist has indicated substantial efficacy https://wholesalepeptides.uk/retatrutide-vs-tirzepatide-the-next-evolution-in-metabolic-enhancement/